Search

Context analysis is a research field that is attracting growing interest in recent years, especially due to the encouraging results carried out by the semantic-based approach. Anyway, semantic strategies entail the use of trackers capable to show robustness to long-term occlusions, viewpoint changes and identity swap that represent the main problem of many tracking-by-detection solutions. This paper proposes a robust tracking-by-detection framework based on dense SIFT descriptors in combination with an ad-hoc target appearance model update able to overtake the discussed issues. The obtained performances show how our tracker competes with state-of-the-art results and manages occlusions, clutter, changes of scale, rotation and appearance, better than competing tracking methods.

Nowadays more and more elderly people need support in daily activities. This is due to the increase of cognitive diseases and other conditions which lead the elderly to not being self-sufficient. Considering this, providing an Ambient Assisted Living system could improve significantly people life quality and could support caregivers' tasks. The combination of Ambient Assisted Living systems and information and communication technologies achieve this purpose perfectly. They exploit internet of things and artificial intelligence paradigms to make daily challenges easier for people with neurodegenerative diseases. This work melds technologies mentioned above providing a smart system for elderly to manage goods and fill in shopping lists. It was possible using software, hardware, and cloud systems combined with a neural network aimed to recognise products. The proposed system has been validated both from a functional point of view through a proof-of-concept and quantitatively by a performance analysis of its components.

Purpose Eye involvement has long been appreciated in patients with chronic graft versus host disease (cGVHD). In particular, ocular complications are frequent and can be potentially severe in patients with steroid-refractory cGVHD, and therefore necessitate close monitoring. This prospective study was designed to describe eye manifestations of cGVHD in a large series of patients monitoring them before and after 1 year of extracorporeal photochemotherapy (ECP). ECP is a relatively new therapeutic approach based on the biological effects of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet A light (UVA) on mononuclear cells collected by apheresis, and reinfused into the patient.Methods Only patients with steroid-refractory cGVHD under treatment with ECP, who developed cGVHD-related eye symptoms, were selected for the study. Ophthalmologic examination was repeated every 3 months. Only patients with complete recovery of the ocular manifestations and symptoms were considered responsive.Results In our study we observed eye alterations in 24 out of 140 patients (17%) with cGVHD. After 12 months of ECP, 10 out of 21 patients (48%) completely responded to the therapy. In all these cases the contribution of ECP was also essential in all the other organs subject to cGVHD.Conclusions Further studies are necessary to clarify the role of ECP in patients with cGVHD, especially in associated eye manifestations. Although our experience is limited, it suggests that ECP could be a safe and effective therapy for steroid-refractory eye manifestations of cGVHD.

Extracorporeal photochemotherapy (ECP) has been used successfully for the treatment of chronic Graft versus Host Disease (cGvHD). However, the mechanism by which ECP exerts its protective effects remains elusive. Some recent observations have suggested a possible role of certain subsets of T lymphocytes with immunosuppressive properties (T-regulatory cells) that coexpress CD4 and high levels of the interleukin-2 receptor chain: CD4+CD25+ T lymphocytes. We studied whether ECP affects the percentage of these cells in the peripheral blood of patients with cGvHD. The study population consisted of 14 patients with cGvHD refractory to systemic steroids. On enrolment in each cycle of ECP, patients underwent clinical examination, blood chemistry analysis and other instrumental procedures to document and assess involvement of the various organs and systems. For cytofluorimetric identification and phenotyping of CD4+CD25+ T lymphocytes, peripheral blood samples were collected in EDTA anticoagulant before ECP, after 48 hours, and after 6 and 12 months from the start of treatment. The 14 patients in this study received a total of more than 300 cycles of ECP, with only minor side effects. The clinical outcome was negative in 2 patients and positive in 12 patients. Within-subject analysis indicated that the percentage of CD4+CD25+ T lymphocytes before ECP and after 12 months of treatment was significantly increased. Our study confirms that changes in the percentage of CD4+CD25+ T cells induced by ECP could be a central aspect in the cascade of immune events leading to the immunological and clinical effects of this treatment in patients with cGvHD.